isomethyleugenol has been researched along with Mast-Cell Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blatt, K; Cerny-Reiterer, S; Ghanim, V; Hadzijusufovic, E; Heller, G; Herrmann, H; Karlic, H; Mirkina, I; Peter, B; Pickl, WF; Schuch, K; Valent, P; Zöchbauer-Müller, S | 1 |
1 other study(ies) available for isomethyleugenol and Mast-Cell Leukemia
| Article | Year |
|---|---|
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Base Sequence; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; DNA, Neoplasm; Drug Synergism; Fas Ligand Protein; fas Receptor; Female; Humans; Leukemia, Mast-Cell; Male; Mast Cells; Mastocytosis, Systemic; Methylation; Middle Aged; Molecular Sequence Data; Neoplasm Proteins; Point Mutation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-kit; RNA, Small Interfering | 2012 |